Table 2.

Descriptive statistics of measured gelatinolytic activitiy.

HC (n=16) BPH (n=8) PCa (n=34) Omnibus p-value HC vs. BPH HC vs. PCa BPH vs. PCa
240 kDa* 158 134.5 162 0.356 n.s. n.s n.s
Volume × 10−3 [59.5 –266] [89 – 270.5] [114 – 367]
92 kDa (MMP-9)* 609.5 713 1011.5 0.009 n.s 0.003 n.s
Volume × 10−3 [519.3 –737.0] [360.25 – 1185.5] [718 – 1671.3]
72 kDa (MMP-2)* 411 521 360 0.734 n.s n.s n.s
Volume × 10−3 [183.3 – 489.8] [183.8 – 828.3] [272.75 – 872.3]
MMP-9/MMP-2,* 1.7 1.56 2.59 0.002 n.s 0.045 0.003
[1.23 – 2.54] [1.15 – 2.07] [2.2 – 3.17]

HC= Healthy Control; BPH=Benign Prostate Hyperplasia; PCa=Prostate Carcinoma; n.s.= non significant

*Data are expressed as median [25th–75th percentile]. Group comparison was based on Kruskall-Wallis test followed by Bonferroni adjusted Mann Whitney U test.
2014 July-September; 3(3): 89–95. ISSN: 2240-2594
Published online 2014 October 23.